Felix Bremmer

Papers

Total Citations

H-Index

About

Felix Bremmer is a leading urological pathologist whose work is reshaping prostate cancer surgery through precision diagnostics. His research centers on the interplay between advanced imaging, targeted biopsy, and intraoperative nerve-sparing techniques during robot-assisted radical prostatectomy. Bremmer’s landmark 2021 study, cited 7 times, critically evaluated how multiparametric MRI-targeted biopsy (MRI-PBx) compares to conventional transrectal ultrasound-guided biopsy in guiding the NeuroSAFE procedure—a technique enabling real-time frozen section analysis to preserve neurovascular bundles. His findings demonstrated that MRI-PBx provides superior spatial mapping of tumor location, allowing surgeons to optimize nerve-sparing without compromising oncological control. This contribution directly addresses the challenge of balancing cancer eradication with postoperative functional outcomes like continence and erectile function. By integrating histopathological precision with cutting-edge imaging, Bremmer’s work has informed clinical protocols that reduce positive surgical margins and secondary nerve damage. His research bridges radiology, surgery, and pathology, offering a roadmap for personalized treatment in localized prostate cancer. For students and clinicians, Bremmer exemplifies how translational pathology can refine surgical decision-making, ultimately improving quality of life for patients.